医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEWS > Home > > 疾病 > AIDS >

AHF Global World AIDS Day Events Focus On Testing and Treatment

2014年11月29日 AM10:10
このエントリーをはてなブックマークに追加


 

PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty million HIV-positive people to treatment by the end of 2020. For more information, visit www.aidshealth.org/wad (Click on the “Worldwide Events” tab for list of international events.)

For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for ...

For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty million HIV-positive people to treatment by the end of 2020. For more information, visit www.aidshealth.org/wad (Click on the “Worldwide Events” tab for list of international events.) WHERE: An AHF healthcare worker administers an HIV test during the Cambodia Water Festival. WHEN: November 2014 (Photo: Business Wire)

WHERE: An AHF healthcare worker administers an HIV test during the Cambodia Water Festival
WHEN: November 2014

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141128005483/en/

CONTACT

AIDS Healthcare Foundation
Ged Kenslea, +1 323-308-1833 or
323-791-5526 (mobile)
ged.kenslea@aidshealth.org
or
Christopher
Johnson
, +1 323-960-4846 or 310-880-9913
(mobile)
christopher.johnson@aidshealth.org

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続